Literature DB >> 6792424

Relapsing experimental allergic encephalomyelitis in the SJL/J mouse.

A M Brown, D E McFarlin.   

Abstract

A single injection dose-response curve was done in the SJL/J mouse using varying amounts of syngeneic spinal cord homogenate and Mycobacterium tuberculosis H37RA in a Freund's type of adjuvant. Inoculation with as little as 0.025 mg. of cord homogenate induced severe experimental allergic encephalomyelitis in some mice. Possible reasons for the great ease of induction of experimental allergic encephalomyelitis with this single injection regimen in comparison with other single injection schemes are discussed. No single injection dose combination was found that induced severe experimental allergic encephalomyelitis in all of a group of mice. When two injections 1 week apart were given, all mice so injected developed severe experimental allergic encephalomyelitis, all had relapses, and nine of 10 had multiple relapses. The number of relapses and severity of residual neurologic deficits were much greater in the two-injection group than in the single injection group.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792424

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  50 in total

1.  Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.

Authors:  Laurence M Howard; Serge Ostrovidov; Cassandra E Smith; Mauro C Dal Canto; Stephen D Miller
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

Authors:  R J Butterfield; E P Blankenhorn; R J Roper; J F Zachary; R W Doerge; C Teuscher
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.

Authors:  Leslie E Summers deLuca; Natalia B Pikor; Jennifer O'Leary; Georgina Galicia-Rosas; Lesley A Ward; Dustin Defreitas; Trisha M Finlay; Shalina S Ousman; Lucy R Osborne; Jennifer L Gommerman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

4.  Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.

Authors:  B E Theien; C L Vanderlugt; T N Eagar; C Nickerson-Nutter; R Nazareno; V K Kuchroo; S D Miller
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

5.  Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood-brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis.

Authors:  A S Lossinsky; V Badmajew; J A Robson; R C Moretz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; H Ovadia; R Mizrachi-Koll; A Ben-Nun; O Abramsky; S Slavin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses.

Authors:  Veronica Sanna; Antonio Di Giacomo; Antonio La Cava; Robert I Lechler; Silvia Fontana; Serafino Zappacosta; Giuseppe Matarese
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Joseph R Merrill; Yongjuan Xia; Woomi Ban; Stephanie M Cohen; Bentley R Midkiff; Valerie Jewells; Yen-Yu I Shih; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

9.  Acute experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice.

Authors:  R Korngold; A Feldman; L B Rorke; F D Lublin; P C Doherty
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

10.  Experimental autoimmune myositis in SJL/J mice.

Authors:  N L Rosenberg; S P Ringel; B L Kotzin
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.